通訊局批准電盈媒體股權結構變動
通訊事務管理局公布,批准本地收費電視節目服務持牌機構電盈媒體提出的股權結構變動申請,是次申請涉及電盈媒體與其母公司電訊盈科(00008.HK)之間的若干中介公司進行改組。
根據電盈媒體提交的資料,電訊盈科是次改組旨在增強該集團旗下收費電視業務與固定/流動電訊業務的協同效應,從而提升營運效率。有關的股權結構變動今日(9月30日)完成後,電盈媒體成為香港電訊(06823.HK)的全資附屬公司,而電訊盈科仍然是香港電訊持有的電盈媒體具表決權股份的最終表決控權人。
通訊局信納電盈媒體在股權變動完成後,會繼續遵守《廣播條例》及其收費電視牌照所有對其適用的規管要求,並會按照牌照條款履行其投資承諾,故批准有關申請。(el/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.